Parametric Portfolio Associates’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-141,892
| Closed | -$1.76M | – | 3877 |
|
|
2016
Q4 | $1.76M | Buy |
141,892
+57,596
| +68% | +$694K | ﹤0.01% | 2458 |
|
|
2016
Q3 | $1.15M | Buy |
84,296
+11,047
| +15% | +$111K | ﹤0.01% | 2716 |
|
|
2016
Q2 | $541K | Buy |
73,249
+6,155
| +9% | +$46.2K | ﹤0.01% | 3145 |
|
|
2016
Q1 | $429K | Sell |
67,094
-37,901
| -36% | -$212K | ﹤0.01% | 3413 |
|
|
2015
Q4 | $656K | Sell |
104,995
-297,817
| -74% | -$1.95M | ﹤0.01% | 3082 |
|
|
2015
Q3 | $2.35M | Sell |
402,812
-7,466
| -2% | -$57.5K | ﹤0.01% | 1724 |
|
|
2015
Q2 | $3.39M | Sell |
410,278
-150,996
| -27% | -$1.34M | 0.01% | 1747 |
|
|
2015
Q1 | $4.63M | Buy |
561,274
+1,654
| +0.3% | +$12.2K | 0.01% | 1398 |
|
|
2014
Q4 | $3.85M | Sell |
559,620
-26,121
| -4% | -$163K | 0.01% | 1503 |
|
|
2014
Q3 | $3.16M | Buy |
585,741
+40,486
| +7% | +$236K | 0.01% | 1606 |
|
|
2014
Q2 | $3.47M | Buy |
545,255
+50,091
| +10% | +$344K | 0.01% | 1522 |
|
|
2014
Q1 | $3.99M | Buy |
495,164
+14,896
| +3% | +$116K | 0.01% | 1333 |
|
|
2013
Q4 | $3.27M | Buy |
480,268
+416,935
| +658% | +$2.25M | 0.01% | 1503 |
|
|
2013
Q3 | $1.17M | Buy |
63,333
+14,245
| +29% | +$277K | ﹤0.01% | 2435 |
|
|
2013
Q2 | $859K | Buy |
+49,088
| New | +$870K | ﹤0.01% | 2555 |
|
Other funds holding ARIA
Parametric Portfolio Associates's ARIA Position: Q1 2017 in Review
Parametric Portfolio Associates sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 141,892 shares — an estimated $1.76M sold.
Parametric Portfolio Associates first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $4.63M in Q1 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Parametric Portfolio Associates reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Parametric Portfolio Associates sold 141,892 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.76M.
- Parametric Portfolio Associates first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- Parametric Portfolio Associates's Ariad Pharmaceuticals Inc position peaked at $4.63M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Parametric Portfolio Associates's 13F filing for Q1 2017, filed 8 May 2017.